SIRT7 downregulation promotes breast cancer metastasis by increasing TGF-β signaling; this effect can be reversed by resveratrol treatment, which activates SIRT7 and promotes deacetylation of SMAD4, a central mediator of TGF-β signaling, thereby increasing cancer patient survival (96). Here, TGFB1 is linked to breast cancer.